Rika Wakao
5PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Oct 27, 2022
Analysis and enhancement of risk management for ethnic differences in antineoplastic drugs in Japan.Shinobu Uzu, Jun Sato, Rika Wakao
|Sep 16, 2021
Pharmaceuticals and Medical Devices Agency's horizon scanning and the Science Board: Cooperation toward extracellular vesicle-based products.Ai Fukaya-Shiba, Masafumi Shimokawa, Hajime Sasaki
|Apr 10, 2021
The Use of Subgroup Disproportionality Analyses to Explore the Sensitivity of a Global Database of Individual Case Safety Reports to Known Pharmacogenomic Risk Variants Common in Japan.Rika Wakao, Ingrid M Lönnstedt, Yasunori Aoki
|Jul 04, 2020
Interstitial Lung Disease as an Adverse Drug Reaction in Japan: Exploration of Regulatory Actions as a Basis for High Reporting.Eiko Iwasa, Yu Fujiyoshi, Yuki Kubota
Pageof 1